TENX
Tenax Therapeutics Inc
1.90$
-2.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +228.0% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -15.1% | +2.4% | +2.1% | +2.9% | +1.4% | +1.8% | +2.4% | -96.9% | +11.7% | +0.0% | +367.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -21.8% | -18.9% | -40.4% | -79.2% | -99.6% | +5,638.3% | +431.1% | +16.5% | +39.8% | -4.8% | +34.5% | +41.2% | +55.1% | -5.6% | -5.0% | -17.4% | -15.3% | +2,411.5% | -96.9% | +67.7% | -21.2% | +28.6% | +29.4% | +1.0% | -26.3% | -76.6% | -25.5% | +438.6% | +59.4% | +57.5% | -13.0% | +33.7% | +47.6% | +23.7% | +7.7% | +68.7% | +2.1% | +9.5% | +11.4% | – | |
| – | +56.3% | -26.8% | +23.8% | -41.0% | +31.7% | -16.3% | +35.5% | -24.5% | +44.4% | -31.5% | -0.7% | +14.8% | +3.6% | -4.9% | -34.3% | +34.9% | +65.6% | -29.3% | -7.4% | +107.7% | -58.5% | +40.6% | -13.2% | +3.0% | +3.1% | -10.3% | -18.5% | +1.3% | +56.1% | -24.9% | +9.0% | +12.1% | +79.3% | +109.4% | +0.3% | +14.2% | -8.8% | -14.8% | +17.9% | – | |
| – | +739.3% | -90.7% | -13.8% | -56.5% | +5.5% | -11.5% | +54.4% | -17.7% | +43.3% | -25.4% | +9.5% | +24.2% | +24.5% | -5.3% | -180.4% | – | +27.3% | -938.2% | – | – | – | -184.6% | – | – | – | -92.1% | -180.3% | – | – | +17.2% | -6.1% | -225.8% | – | +55.4% | +4.0% | +42.5% | -2.1% | +0.8% | +13.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -203.8% | – | – | -91.7% | +93.6% | -184.5% | – | +5.3% | +1.9% | -770.1% | – | – | +71.3% | -257.8% | – | – | – | -257.9% | – | – | – | – | – | – | – | |
| – | +4.8% | -100.0% | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | +50.2% | +0.2% | +0.3% | -45.2% | -100.0% | – | +109.5% | -42.6% | -74.9% | +994.4% | +80.5% | +24.2% | -41.5% | -59.6% | +269.7% | +15.4% | -31.3% | -92.6% | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -106.0% | – | – | – | – | – | – | – | – | -287.0% | – | – | – | -100.1% | – | – | +5.2% | +1.9% | -100.1% | – | -99.7% | -49,814.1% | – | -90.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.